Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersOperating IncomePreferred Dividend PaymentsProfit After TaxRevenueShares Outstanding (Weighted Average)
Others
Ratios

cbdMD (YCBD) EBIT: 2016-2025

Historic EBIT for cbdMD (YCBD) over the last 10 years, with Sep 2025 value amounting to -$2.2 million.

  • cbdMD's EBIT fell 116.65% to -$685,816 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.2 million, marking a year-over-year increase of 34.77%. This contributed to the annual value of -$2.2 million for FY2025, which is 34.77% up from last year.
  • Per cbdMD's latest filing, its EBIT stood at -$2.2 million for FY2025, which was up 34.77% from -$3.3 million recorded in FY2024.
  • In the past 5 years, cbdMD's EBIT registered a high of -$2.2 million during FY2025, and its lowest value of -$78.3 million during FY2022.
  • Over the past 3 years, cbdMD's median EBIT value was -$3.3 million (recorded in 2024), while the average stood at -$9.3 million.
  • Its EBIT has fluctuated over the past 5 years, first slumped by 298.99% in 2022, then soared by 85.26% in 2024.
  • Over the past 5 years, cbdMD's EBIT (Yearly) stood at -$19.6 million in 2021, then slumped by 298.99% to -$78.3 million in 2022, then spiked by 71.27% to -$22.5 million in 2023, then surged by 85.26% to -$3.3 million in 2024, then spiked by 34.77% to -$2.2 million in 2025.